IL209106A0 - Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases - Google Patents

Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases

Info

Publication number
IL209106A0
IL209106A0 IL209106A IL20910610A IL209106A0 IL 209106 A0 IL209106 A0 IL 209106A0 IL 209106 A IL209106 A IL 209106A IL 20910610 A IL20910610 A IL 20910610A IL 209106 A0 IL209106 A0 IL 209106A0
Authority
IL
Israel
Prior art keywords
sulfobetaines
obesity
cancer
macular degeneration
neurodegenerative diseases
Prior art date
Application number
IL209106A
Original Assignee
Tiltan Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2009/000465 external-priority patent/WO2009136396A2/en
Application filed by Tiltan Pharma Ltd filed Critical Tiltan Pharma Ltd
Priority to IL209106A priority Critical patent/IL209106A0/en
Publication of IL209106A0 publication Critical patent/IL209106A0/en

Links

IL209106A 2008-05-05 2010-11-04 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases IL209106A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL209106A IL209106A0 (en) 2008-05-05 2010-11-04 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5041708P 2008-05-05 2008-05-05
PCT/IL2009/000465 WO2009136396A2 (en) 2008-05-05 2009-05-05 Sulfobetaines for therapy
IL209106A IL209106A0 (en) 2008-05-05 2010-11-04 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases

Publications (1)

Publication Number Publication Date
IL209106A0 true IL209106A0 (en) 2011-01-31

Family

ID=44718637

Family Applications (1)

Application Number Title Priority Date Filing Date
IL209106A IL209106A0 (en) 2008-05-05 2010-11-04 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases

Country Status (1)

Country Link
IL (1) IL209106A0 (en)

Similar Documents

Publication Publication Date Title
HRP20181423T1 (en) Gene therapy for neurodegenerative disorders
EP2480230A4 (en) Dr5 ligand drug conjugates
HK1175476A1 (en) Cancer treatment
PL2401010T3 (en) Dose setting mechanism
EP2611765A4 (en) Methods for treating neurodegenerative diseases
EP2389388A4 (en) Treatment for obesity
PL2252317T3 (en) Treatment of macular degeneration
EP2514633A4 (en) Seat heater
HK1172330A1 (en) Treatment of macular degeneration
IL210177A0 (en) Substituted tricyclic derivatives against neurodegenerative diseases
EP2397632A4 (en) Assist mechanism for pivoting body
WO2010083208A9 (en) Treating neuropsychiatric diseases
HK1161040A1 (en) Leaf wasabi food product
ZA201201894B (en) Pharmaceutical combination for treating tumor
AP2012006202A0 (en) Cancer starvation therapy.
EP2515645A4 (en) Antifungal therapy
GB0707556D0 (en) Treatment for cancer
IL209106A0 (en) Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases
GB0902916D0 (en) Antibody therapy
GB0902660D0 (en) Biomarkers for neurodegenerative diseases
AU2009904097A0 (en) Treatment of Macular Degeneration
GB0921102D0 (en) Cancer Therapy
GB0913603D0 (en) Cancer therapy
AU2009901405A0 (en) Cancer therapy
GB0919113D0 (en) Therapeutic invention